- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Ceres Nanosciences, LLLP, a biotechnology company using its proprietary Nanotrapô capture particle technology to develop diagnostics and research products, announced today that it has launched the first release of Nanotrapô ESP Particles designed to improve complex biofluid sample processing allowing for the detection of low-abundance proteins that would not otherwise be detected.
The Nanotrapô ESP product targets end users working with a variety of sample types that require a more efficient and powerful method of sample preparation for downstream detection and analysis.
Nanotrapô ESP Particles improve the sensitivity of any gel electrophoresis protein detection method including silver staining, Coomassie Blue, Western Blotting and mass spectroscopy analysis.
The ability to rapidly harvest multiple proteins and peptides from a single sample makes Nanotrapô ESP particles an ideal tool for researchers interested in rapid sample processing of low abundance proteins or for the discovery of unknown proteins and peptides present in samples containing high-abundance interfering proteins.
The use of this technology for these applications has recently been published by Dr. Lance Liotta and Dr. Emanuel Petricoin in the journals Nano Research and Nano Letters in 2008 and 2009. "Currently, the single largest barrier to biomarker measurement is the inherent lack of sensitivity of most proteomics platforms" said Emanuel Petricoin, Ph. D., co-director of the Center for Applied Proteomics and Molecular Medicine at George Mason University. "The Nanotrap ESP technology provides a powerful new sample preparation approach that tremendously increases the concentration of the biomarker, and greatly aids our own disease biomarker research."
About Ceres Nanosciences
Ceres Nanosciences, LLLP is a privately held company focused on the development of diagnostic products using its unique and proprietary Nanotrapô capture particle technology. Ceresí business goals are to develop a number of commercial applications of the Nanotrapô for high-demand diagnostics and other needs in the life science industry.
For more information, please click here
Copyright © Ceres NanosciencesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
A compact, efficient single photon source that operates at ambient temperatures on a chip: Highly directional single photon source concept is expected to lead to a significant progress in producing compact, cheap, and efficient sources of quantum information bits for future appls May 3rd, 2016
Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016
PEN Inc. Announces Strategy to Broaden Clarity Branded Products Business February 4th, 2016
Graphenea increases capacity, reduces prices January 25th, 2016